Cell Free Protein Expression Market – Insights
Cell free protein expression is also called as cell-free protein synthesis, in vitro translation, cell-free translation or in vitro protein expression. It is a well-developed, rapid, and efficient technique for synthesizing proteins in cell lysates rather than cultured cells. Cell free protein expression uses translation machineries to extract the desired cells. It can be done by using various types of mammalian cells, bacteria, plants, and insect cells over conventional in vivo method. For instance, cell free protein expression system works independently and is free of any cellular context, owing to these benefits it is ideal for high-throughput screening of mutagenesis. Moreover, the whole machinery of cell free expression system sets better environment to manufacture membrane proteins, toxic proteins, and proteins that can undergo degradation. Pharmaceutical and biotechnological industries actively utilize these tools for research and developmental activities as well as for genomics and proteomics. Thus, it is a key factor propelling the cell free protein expression market growth over the forecast period.
The global cell free protein expression market sizewas valued at US$ 177.1 million in 2017, and is expected to witness a CAGR of 6.2% over the forecast period (2018 – 2026).
Global Cell Free Protein Expression Market, By End User (Share Analysis (%)), 2017
Source: Coherent Market Insights Analysis (2018)
Robust research and development is expected to drive growth of the cell free protein expression market
Increasing research and development in the field of proteomics and genomics and high prevalence of infectious disease and cancer are the major factors driving growth of the cell free protein expression market. For instance, According to 2012, EU Industrial R&D Investment Scoreboard, the pharmaceutical and biotechnology sectors represented 17.7% of business R&D expenditure in the world. Moreover, high prevalence of infectious disease and cancer cases across the world are resulting into high adoption of cell samples for research and development of drugs thus, expected to have a meteoric growth for the cell free protein expression market. For instance, According to the estimates by GLOBOCAN 2012, an estimated 850,000 new cancer cases were diagnosed in Africa, while almost 600,000 deaths were attributed to malignant disease. The number of cancer cases is expected to rise to 1,056,000 by 2020. Furthermore, According to the World Health Organization (WHO), in 2012, around 3,319 deaths occurred due to the infectious and parasitic disease infection, in Sub Saharan Africa region and according to the same source, in 2014, Ebola accounted for around 8,000 deaths in this region.
However, high cost, low yield of protein from certain species, lack of eukaryotic co- and post-translational modifications may hamper the growth of the market. For instance, cell free system based on E.coli and wheat germ extracts have some limitation to produce human proteins with post translation modifications (PTMs), which is restraining growth of the cell free protein expression market growth.
Cell Free Protein Expression Market- Regional Analysis
Cell free protein expression market is segmented into six major regions- North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. Increasing cell-based research in North America due to high demand for precision medicine is a major factor driving growth of the cell free protein expression market in this region. In 2015, the Precision Medicine Initiative was launched in the U.S. to revolutionize the treatment of diseases, which include cancer and other chronic diseases, as precision medicine offers tailored treatment for an individual according to genetic makeup of the person. Furthermore, increasing emphasis on proteomics and genomics research activities in UK, Germany, France, and Switzerland are fueling growth of the European cell free protein expression market. For instance, in 2018, UK Biobank is taking initiative to sequence the full genomes of 50,000 UK Biobank volunteer participants. This initiative is funded £30M (US$ 39.8 Mn) grant from the Medical Research Council (MRC). This investment has accelerates research activities for wide range of diseases associated with disability and premature death in mid to later life. The Asia Pacific is estimated to witness significant growth in cell free protein expression market, owing to increasing number of research laboratories, contract research organizations and pharmaceutical companies with increased expenditure on research and development. For instance, China’s expenditure on research and development increased by 11.6% year-on-year to US$ 280 Bn in 2017.
Cell Free Protein Expression Market- Competitive Landscape
Increasing investments and initiatives by various manufacturers supports growth of the cell free protein expression market over the forecast period. For instance, in September 2017, iBio, Inc. with its subsidiary iBio CDMO LLC, a contract development and manufacturing organization (CDMO) collaborated with TheoremDx, Inc. to develop proteins for rapid diagnostic testing products. The collaboration aims to offer plant proteins through robust development and manufacturing in the U.S. and other economies. IBio is expected to provide an expression system to TheoremDx, which allows establishment of new diagnostics through cGMP scale-up production. Both iBio and TheoremDx are specifically focusing on development of rapid diagnostic tests, which can help in identifying and distinguishing neglected tropical diseases such as Zika, West Nile, Dengue, and Chikungunya. This collaboration is a major strategic step for advancement of rapid detection test internationally.
Key players operating in cell free protein expression market include iBio CDMO LLC, Thermo Fisher Scientific Inc., Takara Bio, Inc., New England Biolabs, Promega Corporation, CellFree Sciences Co., Ltd., Biotechrabbit GmbH, Bioneer Corporation, Cube Biotech GmbH, Jena Bioscience GmbH, and GeneCopoeia, Inc.
Cells contain biomolecules such as proteins or nucleic acids, which are present in the cytoplasm enclosed within a membrane. Cell free protein expression is a process, which require biomolecular translation machinery extracted from cells to produce recombinant proteins. Cell-free protein expression can be accomplished with different cell extracts such as rabbit reticulocytes, E. coli (prokaryotic), wheat germs (eukaryotes), and insect cells. It offers various features and advantages as compared to conventional in vivo methods. The first types of lysates developed for cell-free protein expression were derived from prokaryotic organisms. In recent past, systems based on extracts from insect cells, mammalian cells, and human cells have been developed and made available commercially, which is expected to drive growth of the market during the forecast period.
The global cell free protein expression market is projected to witness significant growth over the forecast period, owing to increasing prevalence of chronic diseases and increasing development in protein synthesis by key market players. For instance, new developments such as Protein Synthesis Using Recombinant Elements (PURE) offer specialized applications such as in vitro protein evolution, protein micro-arrays, and protein labelling. Furthermore, according to the Centers for Disease Control and Prevention (CDC) data findings, 2015, around 5,251 deaths were reported due to influenza infection in 2015, in the U.S., which in turn is propelling demand for advanced biologics such as therapeutic protein for the treatment of chronic diseases. Moreover, increasing research and development investment by biopharmaceutical industries and biotechnology industries is fostering growth of the cell free protein expression market. For instance, Merck & Co., Inc., a leading healthcare company, invested around US$ 10,124 million in R&D in 2016.
Key features of the study:
“*” marked represents similar segmentation in other categories in the respective section.
Table of Contents
*Browse 38 market data tables and 23 figures on "Cell Free Protein Expression Market” - Global forecast to 2025”.
Coherent Market Insights followsa comprehensive research methodology focused on providing the most precise market analysis. The company leverages a data triangulation model which helps company to gauge the market dynamics and provide accurate estimates. Key components of the research methodologies followed for all our market reports include:
In addition to this, Coherent Market Insights has access to a wide range of the regional and global reputed paid data bases, which helps the company to figure out the regional and global market trends and dynamics. The company analyses the industry from the 360 Degree Perspective i.e. from the Supply Side and Demand Side which enables us to provide granular details of the entire ecosystem for each study. Finally, a Top-Down approach and Bottom-Up approach is followed to arrive at ultimate research findings.
Coherent Market Insights desk research is based on a principle set of research techniques:
Coherent Market Insights has a large amount of in-house repository of industry database. This is leveraged as a burner for initiating a new research study. Key secondary sources include:
Preliminary Data Mining
The raw data is obtained through the secondary findings, in house repositories, and trade surveys. It is then filtered to ensure that the relevant information including industry dynamics, trends, and outlook is retained for further research process.
Holistic approach is used to ensure that the granular and uncommon parameters are taken into consideration to ensure accurate results. The information from the paid databases are further combined to the raw data in order to standardize it.
Coherent Statistical model
We arrive at our final research findings through simulation models. Coherent Data Analytics Model is a statistical tool that helps company to forecast market estimates. Few of the parameters considered as a part of the statistical model include:
Once the findings are derived from the statistical model, large volume of data is process to confirm accurate research results. Data analytics and processing tools are adopted to process large chunk of collected informative data. In case, a client customizes the study during the process, the research finding till then are benchmarked, and the process for new research requirement is initiated again.
This is the most crucial stage of the research process. Primary Interviews are conducted to validate the data and analysis. This helps in achieving the following purposes:
The primary research is conducted with the ecosystem players including, but not limited to:
Finding it difficult to find the research that would cater to your business demands? Give us a chance to help you. One of our Research Consultants will connect to provide a customized solution.
Talk to our research consultant to design an exclusive report as per your research needs.
We aim to fulfil client's research demands with tailored research solutions.
We aim to provide research studies in quickest turnaround time and in a much cost effective manner.
We cover each industry from supply and demand side with an aim to provide a most holistic research study.
We strive to provide most accurate and reliable research findings in our research reports.